Cue Biopharma, Inc. (CUE)

Cue Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	37	119	101	359	379	365
Market Cap Growth	-40.34%	18.12%	-71.93%	-5.17%	3.77%	285.76%
Enterprise Value	6	82	41	302	298	309
PE Ratio	-	-2.35	-1.90	-8.13	-8.46	-9.95
PS Ratio	5.28	21.70	81.00	24.04	120.08	105.55
PB Ratio	1.23	3.21	1.54	5.49	4.80	6.69
P/FCF Ratio	-2.36	-2.98	-2.40	-9.04	-11.45	-11.88
P/OCF Ratio	-2.36	-2.98	-2.41	-9.25	-11.66	-11.85
EV/Sales Ratio	0.88	15.02	32.62	20.21	94.58	89.26
EV/EBITDA Ratio	-1.37	-1.79	-0.80	-7.12	-6.85	-8.70
EV/EBIT Ratio	-1.25	-1.67	-0.78	-6.92	-6.69	-8.51
EV/FCF Ratio	-1.57	-2.06	-0.97	-7.60	-9.02	-10.05
Debt / Equity Ratio	0.43	0.40	0.29	0.15	0.09	0.11
Debt / EBITDA Ratio	-0.29	-0.32	-0.38	-0.24	-0.16	-0.16
Debt / FCF Ratio	-0.33	-0.37	-0.46	-0.25	-0.22	-0.19
Quick Ratio	2.50	3.11	6.89	5.50	5.46	5.40
Current Ratio	2.47	3.01	6.68	5.35	5.37	5.24
Asset Turnover	0.11	0.08	0.02	0.18	0.03	0.07
Interest Coverage	-38.47	-39.75	-73.35	-	-	-
Return on Equity (ROE)	-128.30%	-112.30%	-88.00%	-65.00%	-61.40%	-115.90%
Return on Assets (ROA)	-77.60%	-71.10%	-61.80%	-51.90%	-48.70%	-72.00%
Return on Capital (ROIC)	-119.52%	-100.71%	-62.62%	-57.86%	-52.34%	-60.90%
Earnings Yield	-134.94%	-42.59%	-52.56%	-12.29%	-11.82%	-10.05%
FCF Yield	-105.22%	-33.54%	-41.62%	-11.06%	-8.74%	-8.41%
Buyback Yield / Dilution	-10.78%	-28.35%	-13.95%	-9.05%	-30.16%	-9.48%
Total Shareholder Return	-10.78%	-28.35%	-13.95%	-9.05%	-30.16%	-9.48%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).